Basic Information
| LncRNA/CircRNA Name | AC138128.1 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | qPCR etc. |
| Sample | gastric cancer tissues, cell lines (AGS, SGC-7901, BGC-823, HG27) |
| Expression Pattern | down-regulated |
| Function Description | The results showed that the expression level of AC138128.1 in GC was significantly decreased compared to that in NAT. Levels of AC138128.1 in the GC cell lines, AGS BGC-823, HG27, and SGC-7901 were lower than those in the human normal gastric epithelial cell line GES-1. lncRNA AC138128.1 might be a novel biomarker for predicting GC. |
| Pubmed ID | 25260808 |
| Year | 2014 |
| Title | The novel long noncoding RNA AC138128.1 may be a predictive biomarker in gastric cancer. |
External Links
| Links for AC138128.1 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |